Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17,264,276
-
Total 13F shares
-
15,028,755
-
Share change
-
+14,943,755
-
Total reported value
-
$150,646,354
-
Price per share
-
$10.02
-
Number of holders
-
42
-
Value change
-
+$149,794,673
-
Number of buys
-
41
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q4 2024
As of 31 Dec 2024 Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,028,755 shares of stock of the company.
Largest 10 holders included AQR Arbitrage LLC, Magnetar Financial LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, Polar Asset Management Partners Inc., K2 PRINCIPAL FUND, L.P., First Trust Capital Management L.P., Hudson Bay Capital Management LP, TENOR CAPITAL MANAGEMENT Co., L.P., and Linden Advisors LP.
This table shows 42 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.